Rockwell Medical (RMTI) Competitors

$0.67 +0.01 (+1.36%)

As of 10:52 AM Eastern

RMTI vs. ARAY, ABT, ISRG, SYK, and MDT

Should you buy Rockwell Medical stock or one of its competitors? MarketBeat compares Rockwell Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Rockwell Medical include Accuray (ARAY), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), and Medtronic (MDT). These companies are all part of the "health care equipment" industry.

How does Rockwell Medical compare to Accuray?

Rockwell Medical (NASDAQ:RMTI) and Accuray (NASDAQ:ARAY) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations, media sentiment and institutional ownership.

Rockwell Medical has a net margin of -7.98% compared to Accuray's net margin of -10.76%. Rockwell Medical's return on equity of -15.41% beat Accuray's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rockwell Medical	-7.98%	-15.41%	-9.62%
Accuray	-10.76%	-79.43%	-10.38%

Rockwell Medical has a beta of 1.58, suggesting that its stock price is 58% more volatile than the broader market. Comparatively, Accuray has a beta of 1.35, suggesting that its stock price is 35% more volatile than the broader market.

In the previous week, Accuray had 1 more articles in the media than Rockwell Medical. MarketBeat recorded 1 mentions for Accuray and 0 mentions for Rockwell Medical. Accuray's average media sentiment score of 1.27 beat Rockwell Medical's score of 0.00 indicating that Accuray is being referred to more favorably in the news media.

Company	Overall Sentiment
Rockwell Medical	Neutral
Accuray	Positive

23.3% of Rockwell Medical shares are owned by institutional investors. Comparatively, 64.1% of Accuray shares are owned by institutional investors. 1.9% of Rockwell Medical shares are owned by insiders. Comparatively, 4.4% of Accuray shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Rockwell Medical currently has a consensus target price of $2.00, suggesting a potential upside of 199.85%. Accuray has a consensus target price of $2.00, suggesting a potential upside of 511.62%. Given Accuray's higher probable upside, analysts clearly believe Accuray is more favorable than Rockwell Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Accuray	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Accuray has higher revenue and earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Accuray, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rockwell Medical	$69.26M	0.38	-$5.31M	-$0.15	N/A
Accuray	$428.57M	0.09	-$1.59M	-$0.37	N/A

Summary

Rockwell Medical and Accuray tied by winning 8 of the 16 factors compared between the two stocks.

How does Rockwell Medical compare to Abbott Laboratories?

Rockwell Medical (NASDAQ:RMTI) and Abbott Laboratories (NYSE:ABT) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, media sentiment, dividends and valuation.

In the previous week, Abbott Laboratories had 45 more articles in the media than Rockwell Medical. MarketBeat recorded 45 mentions for Abbott Laboratories and 0 mentions for Rockwell Medical. Abbott Laboratories' average media sentiment score of 1.16 beat Rockwell Medical's score of 0.00 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company	Overall Sentiment
Rockwell Medical	Neutral
Abbott Laboratories	Positive

23.3% of Rockwell Medical shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 1.9% of Rockwell Medical shares are held by company insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Abbott Laboratories has higher revenue and earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rockwell Medical	$69.26M	0.38	-$5.31M	-$0.15	N/A
Abbott Laboratories	$45.13B	3.54	$6.52B	$3.57	25.72

Rockwell Medical has a beta of 1.58, meaning that its share price is 58% more volatile than the broader market. Comparatively, Abbott Laboratories has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market.

Rockwell Medical currently has a consensus target price of $2.00, indicating a potential upside of 199.85%. Abbott Laboratories has a consensus target price of $119.09, indicating a potential upside of 29.71%. Given Rockwell Medical's higher probable upside, equities analysts plainly believe Rockwell Medical is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Abbott Laboratories	0 Sell rating(s)	5 Hold rating(s)	19 Buy rating(s)	2 Strong Buy rating(s)	2.88

Abbott Laboratories has a net margin of 13.90% compared to Rockwell Medical's net margin of -7.98%. Abbott Laboratories' return on equity of 17.62% beat Rockwell Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rockwell Medical	-7.98%	-15.41%	-9.62%
Abbott Laboratories	13.90%	17.62%	10.01%

Summary

Abbott Laboratories beats Rockwell Medical on 14 of the 17 factors compared between the two stocks.

How does Rockwell Medical compare to Intuitive Surgical?

Intuitive Surgical (NASDAQ:ISRG) and Rockwell Medical (NASDAQ:RMTI) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, valuation, institutional ownership, profitability, risk and analyst recommendations.

Intuitive Surgical has a net margin of 28.15% compared to Rockwell Medical's net margin of -7.98%. Intuitive Surgical's return on equity of 15.98% beat Rockwell Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intuitive Surgical	28.15%	15.98%	14.07%
Rockwell Medical	-7.98%	-15.41%	-9.62%

In the previous week, Intuitive Surgical had 46 more articles in the media than Rockwell Medical. MarketBeat recorded 46 mentions for Intuitive Surgical and 0 mentions for Rockwell Medical. Intuitive Surgical's average media sentiment score of 0.93 beat Rockwell Medical's score of 0.00 indicating that Intuitive Surgical is being referred to more favorably in the media.

Company	Overall Sentiment
Intuitive Surgical	Positive
Rockwell Medical	Neutral

83.6% of Intuitive Surgical shares are held by institutional investors. Comparatively, 23.3% of Rockwell Medical shares are held by institutional investors. 0.6% of Intuitive Surgical shares are held by insiders. Comparatively, 1.9% of Rockwell Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Intuitive Surgical currently has a consensus price target of $573.63, indicating a potential upside of 33.95%. Rockwell Medical has a consensus price target of $2.00, indicating a potential upside of 199.85%. Given Rockwell Medical's higher probable upside, analysts plainly believe Rockwell Medical is more favorable than Intuitive Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intuitive Surgical	1 Sell rating(s)	7 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.67
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Intuitive Surgical has a beta of 1.46, suggesting that its share price is 46% more volatile than the broader market. Comparatively, Rockwell Medical has a beta of 1.58, suggesting that its share price is 58% more volatile than the broader market.

Intuitive Surgical has higher revenue and earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intuitive Surgical	$10.06B	15.07	$2.86B	$8.25	51.91
Rockwell Medical	$69.26M	0.38	-$5.31M	-$0.15	N/A

Summary

Intuitive Surgical beats Rockwell Medical on 13 of the 16 factors compared between the two stocks.

How does Rockwell Medical compare to Stryker?

Stryker (NYSE:SYK) and Rockwell Medical (NASDAQ:RMTI) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.

Stryker has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market. Comparatively, Rockwell Medical has a beta of 1.58, suggesting that its share price is 58% more volatile than the broader market.

77.1% of Stryker shares are owned by institutional investors. Comparatively, 23.3% of Rockwell Medical shares are owned by institutional investors. 4.6% of Stryker shares are owned by company insiders. Comparatively, 1.9% of Rockwell Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Stryker has a net margin of 13.20% compared to Rockwell Medical's net margin of -7.98%. Stryker's return on equity of 23.42% beat Rockwell Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stryker	13.20%	23.42%	11.04%
Rockwell Medical	-7.98%	-15.41%	-9.62%

Stryker presently has a consensus target price of $395.33, indicating a potential upside of 28.14%. Rockwell Medical has a consensus target price of $2.00, indicating a potential upside of 199.85%. Given Rockwell Medical's higher possible upside, analysts clearly believe Rockwell Medical is more favorable than Stryker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stryker	0 Sell rating(s)	6 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	2.73
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Stryker had 27 more articles in the media than Rockwell Medical. MarketBeat recorded 27 mentions for Stryker and 0 mentions for Rockwell Medical. Stryker's average media sentiment score of 1.29 beat Rockwell Medical's score of 0.00 indicating that Stryker is being referred to more favorably in the media.

Company	Overall Sentiment
Stryker	Positive
Rockwell Medical	Neutral

Stryker has higher revenue and earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Stryker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stryker	$25.12B	4.71	$3.25B	$8.64	35.71
Rockwell Medical	$69.26M	0.38	-$5.31M	-$0.15	N/A

Summary

Stryker beats Rockwell Medical on 14 of the 16 factors compared between the two stocks.

How does Rockwell Medical compare to Medtronic?

Medtronic (NYSE:MDT) and Rockwell Medical (NASDAQ:RMTI) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability and analyst recommendations.

82.1% of Medtronic shares are owned by institutional investors. Comparatively, 23.3% of Rockwell Medical shares are owned by institutional investors. 0.3% of Medtronic shares are owned by insiders. Comparatively, 1.9% of Rockwell Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Medtronic has a net margin of 13.20% compared to Rockwell Medical's net margin of -7.98%. Medtronic's return on equity of 14.61% beat Rockwell Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medtronic	13.20%	14.61%	7.80%
Rockwell Medical	-7.98%	-15.41%	-9.62%

In the previous week, Medtronic had 97 more articles in the media than Rockwell Medical. MarketBeat recorded 97 mentions for Medtronic and 0 mentions for Rockwell Medical. Medtronic's average media sentiment score of 0.54 beat Rockwell Medical's score of 0.00 indicating that Medtronic is being referred to more favorably in the media.

Company	Overall Sentiment
Medtronic	Positive
Rockwell Medical	Neutral

Medtronic has higher revenue and earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medtronic	$36.36B	2.89	$4.80B	$3.73	21.95
Rockwell Medical	$69.26M	0.38	-$5.31M	-$0.15	N/A

Medtronic has a beta of 0.58, suggesting that its stock price is 42% less volatile than the broader market. Comparatively, Rockwell Medical has a beta of 1.58, suggesting that its stock price is 58% more volatile than the broader market.

Medtronic currently has a consensus price target of $99.00, indicating a potential upside of 20.91%. Rockwell Medical has a consensus price target of $2.00, indicating a potential upside of 199.85%. Given Rockwell Medical's higher possible upside, analysts clearly believe Rockwell Medical is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medtronic	0 Sell rating(s)	11 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.61
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Medtronic beats Rockwell Medical on 13 of the 16 factors compared between the two stocks.

Get Rockwell Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RMTI vs. The Competition

Export

Metric	Rockwell Medical	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$26.37M	$8.41B	$6.47B	$12.16B
Dividend Yield	N/A	2.52%	2.67%	5.58%
P/E Ratio	-4.45	16.44	23.96	24.11
Price / Sales	0.38	5.72	535.67	120.23
Price / Cash	N/A	17.45	26.99	37.25
Price / Book	0.71	3.64	10.54	6.88
Net Income	-$5.31M	$225.32M	$3.56B	$337.04M
7 Day Performance	-5.94%	2.29%	1.51%	-0.83%
1 Month Performance	-20.00%	3.97%	4.47%	3.46%
1 Year Performance	-35.24%	-1.77%	23.87%	27.46%

Rockwell Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RMTI Rockwell Medical	2.0966 of 5 stars	$0.67 +1.4%	$2.00 +198.5%	-35.2%	$26.48M	$69.26M	N/A	300	Gap Up
ARAY Accuray	3.0884 of 5 stars	$0.37 -1.2%	$2.00 +434.8%	-72.5%	$45.02M	$458.51M	N/A	1,040	Positive News Gap Down
ABT Abbott Laboratories	4.9603 of 5 stars	$86.54 +1.1%	$119.09 +37.6%	-32.3%	$149.10B	$44.33B	24.54	115,000
ISRG Intuitive Surgical	4.1652 of 5 stars	$400.96 -5.6%	$576.71 +43.8%	-24.9%	$146.01B	$10.58B	49.89	17,021
SYK Stryker	4.9062 of 5 stars	$293.79 -3.7%	$395.48 +34.6%	-21.5%	$116.96B	$25.27B	34.41	56,000	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RMTI) was last updated on 6/9/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rockwell Medical (RMTI) Competitors

RMTI vs. ARAY, ABT, ISRG, SYK, and MDT

How does Rockwell Medical compare to Accuray?

Summary

How does Rockwell Medical compare to Abbott Laboratories?

Summary

How does Rockwell Medical compare to Intuitive Surgical?

Summary

How does Rockwell Medical compare to Stryker?

Summary

How does Rockwell Medical compare to Medtronic?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RMTI vs. The Competition

Rockwell Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Rockwell Medical (RMTI) Competitors

RMTI vs. ARAY, ABT, ISRG, SYK, and MDT

How does Rockwell Medical compare to Accuray?

Is RMTI or ARAY more profitable?

Which has more volatility and risk, RMTI or ARAY?

Does the media refer more to RMTI or ARAY?

Do institutionals & insiders hold more shares of RMTI or ARAY?

Do analysts recommend RMTI or ARAY?

Which has preferable valuation & earnings, RMTI or ARAY?

Summary

How does Rockwell Medical compare to Abbott Laboratories?

Does the media refer more to RMTI or ABT?

Do insiders and institutionals believe in RMTI or ABT?

Which has stronger valuation and earnings, RMTI or ABT?

Which has more volatility and risk, RMTI or ABT?

Do analysts rate RMTI or ABT?

Is RMTI or ABT more profitable?

Summary

How does Rockwell Medical compare to Intuitive Surgical?

Is ISRG or RMTI more profitable?

Does the media prefer ISRG or RMTI?

Do insiders & institutionals hold more shares of ISRG or RMTI?

Do analysts rate ISRG or RMTI?

Which has more volatility & risk, ISRG or RMTI?

Which has stronger valuation and earnings, ISRG or RMTI?

Summary

How does Rockwell Medical compare to Stryker?

Which has more risk and volatility, SYK or RMTI?

Do institutionals and insiders hold more shares of SYK or RMTI?

Is SYK or RMTI more profitable?

Do analysts rate SYK or RMTI?

Does the media favor SYK or RMTI?

Which has better earnings & valuation, SYK or RMTI?

Summary

How does Rockwell Medical compare to Medtronic?

Do institutionals & insiders hold more shares of MDT or RMTI?

Is MDT or RMTI more profitable?

Does the media favor MDT or RMTI?

Which has higher earnings and valuation, MDT or RMTI?

Which has more risk & volatility, MDT or RMTI?

Do analysts rate MDT or RMTI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RMTI vs. The Competition

Rockwell Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools